UCSF

ZINC00001792

Substance Information

In ZINC since Heavy atoms Benign functionality
September 29th, 2005 16 No

Other Names:

(3-(Dimethylcarbamoxy)phenyl)trimethylammonium methyl sulfate; (3-(Dimethylcarbamoyl)oxyphenyl)trimethylammonium methyl sulfate; (3-Hydroxyphenyl)trimethylammonium methyl sulfate dimethylcarbamic ester; (m-Hydroxyphenyl)trimethylammonium methyl sulfate di

(m-Hydroxyphenyl)trimethylammonium bromide dimethylcarbamate; 3-Dimethylcarbamoxyphenyl trimethyl ammonium bromide; 3-Hydroxyphenyltrimethylammonium bromide dimethylcarbamic ester; Ammonium, (m-hydroxyphenyl)trimethyl-, bromide, dimethylcarbamate; Benzena

(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate

(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate (ester)

(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate (ester); 3-Trimethylammoniumphenyl N,N-dimethylcarbamate; Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate (ester); BRN 3615946; Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-

(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate; 3-Trimethylammoniumphenyl N,N-dimethylcarbamate; 3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium; 3-{[(dimethylamino)carbonyl]oxy}-N,N,N-trimethylanilinium; Eustigmin; Eustigmine; Neostigmine; Pros

(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate; 3-Trimethylammoniumphenyl N,N-dimethylcarbamate; Eustigmin; Eustigmine; Neostigmine; Prostigmine; Vagostigmine; m-Trimethylammoniumphenyldimethylcarbamate

stigmine

114-80-7 (bromide)

114-80-7; C08197; Neo proserine; Neostigmine bromide

114-80-7; D00995; Neostigmine bromide (JAN/USP/INN); Vagostigmin (TN)

114-80-7; Neostigmine bromide; Prestwick_352

3-((Dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium bromide

3-((Dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium methyl sulfate

3-(N,N-Dimethylcarbamoyloxy)-N,N,N,-trimethylanilinium bromide

3-Trimethylammoniumphenyl N,N-dimethylcarbamate

3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium

3-[[(Dimethylamino)carbonyl]oxy]-N,N,N-trimethylbenzenaminium methyl sulfate

3-{[(dimethylamino)carbonyl]oxy}-N,N,N-trimethylanilinium

342

51-60-5 (methyl sulfate)

51-60-5; C08200; Neostigmine methylsulfate

51-60-5; D00998; Neostigmine methylsulfate (JP16/USP); Prostigmin (TN)

59-99-4

59-99-4; C07258; Neostigmine

59-99-4; D08261; Neostigmine (BAN); Prostigmin (TN)

AB00053807

AC1L1I7G

ALWKGYPQUAPLQC-UHFFFAOYSA-

Ammonium, (3-(dimethylcarbamoyloxy)phenyl)trimethyl-, iodide; Ammonium, (m-hydroxyphenyl)trimethyl-, iodide, dimethylcarbamate; Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-, iodide; Carbamic acid, N,N-dimethyl-, 3-dimethylaminophenyl e

Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate (ester)

Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-

Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl- (9CI)

bmse000762

BPBio1_000634

BRD-K18922609-004-04-1

BRN 3615946

BSPBio_000576

C07258

CAS-114-80-7

CCRIS 3079

CHEBI:7514

CHEBI:7515

CID4456

D08261

DAP000563

DB01400

DivK1c_000165

DivK1c_000198

Eustigmin

Eustigmine

HMS2089A22

HSDB 3921

IDI1_000165

IDI1_000198

InChI=1/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1

INN

Intrastigmina

JAN

Juvastigmin

KBio1_000165

KBio1_000198

KBio2_001541

KBio2_004109

KBio2_006677

KBioGR_000623

KBioSS_001541

LS-18452

m-Trimethylammoniumphenyldimethylcarbamate

Methanesulfonate(3-dimethylcarbamoyloxy-phenyl)-trimethyl-ammonium

MFCD00011795

MFCD00011796

MFCD01558739

NCGC00015730-01

NCGC00015730-02

NCGC00015730-03

NCGC00015730-04

NCGC00015730-08

NCGC00021658-03

NCGC00163240-01

nchembio.188-comp33

Neostigmin

Neostigmine

Neostigmine (BAN)

Neostigmine (BAN); Neostigmine Methylsulfate (FDA

Neostigmine (BAN); Neostigmine Methylsulfate (JAN

Neostigmine (Bromide)

Neostigmine (methyl sulfate)

Neostigmine bromide (Prostigmin)

Neostigmine bromide; >99%

Neostigmine Mesilate

NEOSTIGMINE METHYL SULFATE

Neostigmine methyl sulphate; >98%

Neostigmine methylsulfate

Neostigmine omega

Neostigmine [BAN]

Neostigminebromide

Neostigminum

NINDS_000165

NINDS_000198

Prestwick0_000468

Prestwick1_000468

Prestwick2_000468

Prestwick3_000468

Proserin

Prostigmin

Prostigmin (TN)

Prostigmin, Vagostigmin

Prostigmine

Prozerin

QA-7651

SPBio_001276

SPBio_002515

Spectrum2_001278

Spectrum4_000072

Spectrum5_001234

Spectrum_001061

STL058953

sulfonatooxymethane

Synstigmin

Synstigmine

Syntostigmine

UNII-3982TWQ96G

USP)

USP); Neostigmine Bromide (BAN

Vagostigmin

Vagostigmine

ZINC00001792

[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium

[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium bromide

[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium

[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium bromide

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -2.34 7.92 -35.58 0 4 1 30 223.296 3

Vendor Notes

Note Type Comments Provided By
Molecular_Solubility 2.53 Bitter DB
MP 146 TCI
ALOGPS_SOLUBILITY 6.77e-02 g/l DrugBank-approved
Target AChR Selleck Chemicals
mechanism Along with several other drugs that have a similar mode of action, it inhibits the action of the enzyme cholinesterase, which destroys the substance acetylcholine at nerve endings. IBScreen Bioactives
biological_use Anticholinesterase IBScreen Bioactives
mechanism Because neostigmine increases the effective concentration of acetylcholine IBScreen Bioactives
therap cholinergic MicroSource Spectrum
mechanism Parasympathomimetic IBScreen Bioactives IBScreen Bioactives
Therapy Reversible inhibitor of acetylcholinesterase SMDC Iconix

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
ACES-10-E Acetylcholinesterase (cluster #10 Of 12), Eukaryotic Eukaryotes 40 0.65 Binding ≤ 10μM
CHLE-1-E Butyrylcholinesterase (cluster #1 Of 7), Eukaryotic Eukaryotes 800 0.53 Binding ≤ 10μM
Z50501-3-O Gallus Gallus (cluster #3 Of 3), Other Other 28 0.66 Functional ≤ 10μM
Z50512-1-O Cavia Porcellus (cluster #1 Of 7), Other Other 28 0.66 Functional ≤ 10μM
Z50594-1-O Mus Musculus (cluster #1 Of 9), Other Other 900 0.53 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
ACES_RAT P37136 Acetylcholinesterase, Rat 37.5 0.65 Binding ≤ 1μM
ACES_HUMAN P22303 Acetylcholinesterase, Human 18.8 0.68 Binding ≤ 1μM
ACES_ELEEL O42275 Acetylcholinesterase, Eleel 1000 0.53 Binding ≤ 1μM
CHLE_HUMAN P06276 Butyrylcholinesterase, Human 60 0.63 Binding ≤ 1μM
ACES_HUMAN P22303 Acetylcholinesterase, Human 18.8 0.68 Binding ≤ 10μM
ACES_ELEEL O42275 Acetylcholinesterase, Eleel 1000 0.53 Binding ≤ 10μM
ACES_RAT P37136 Acetylcholinesterase, Rat 37.5 0.65 Binding ≤ 10μM
CHLE_HUMAN P06276 Butyrylcholinesterase, Human 60 0.63 Binding ≤ 10μM
Z50512 Z50512 Cavia Porcellus 28 0.66 Functional ≤ 10μM
Z50501 Z50501 Gallus Gallus 28 0.66 Functional ≤ 10μM
Z50594 Z50594 Mus Musculus 900 0.53 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Neurotransmitter Clearance In The Synaptic Cleft
Synthesis of PC
Synthesis, secretion, and deacylation of Ghrelin

Analogs ( Draw Identity 99% 90% 80% 70% )